Printer Friendly

IMMULOGIC PHARMACEUTICAL SELLS 133,000 SHARES THROUGH EXERCISE OF OVER-ALLOTMENT

IMMULOGIC PHARMACEUTICAL SELLS 133,000 SHARES THROUGH EXERCISE OF
 OVER-ALLOTMENT
 CAMBRIDGE, Jan. 28 /PRNewswire/ -- ImmuLogic Pharmaceutical Corporation (NASDAQ: IMUL) today announced that the underwriters of the company's recently completed public offering have exercised an option to purchase 133,000 additional shares of common stock to cover over-allotments from the offering.
 Including the over-allotment, a total of 2,133,000 shares were sold for $22.75 per share. The underwriters for the offering were Morgan Stanley & Co. Incorporated and Hambrecht & Quist Incorporated.
 ImmuLogic is developing products to treat allergies and autoimmune diseases. The company's technical approach is based upon proprietary discoveries and an advanced understanding of the molecular events controlling the human immune system. ImmuLogic is developing a family of ALLERVAX(tm) products to treat allergic diseases and the company has recently announced an agreement with Marion Merrell Dow Inc. to collaborate on the worldwide commercialization of these products. The company is also collaborating with Merck & Co. to develop treatments for Type I diabetes and rheumatoid arthritis.
 -0- 1/28/92
 /CONTACT: Janet C. Bush, vice president, finance and administration of ImmuLogic Pharmaceutical Corporation, 617-494-0060/
 (IMUL) CO: ImmuLogic Pharmaceutical Corporation ST: Massachusetts IN: MTC SU: OFR


EG-SH -- NE006 -- 4132 01/28/92 10:16 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 28, 1992
Words:204
Previous Article:BURNHAM PACIFIC PROPERTIES' SHAREHOLDERS OK MERGER
Next Article:NOVA PHARMACEUTICAL ANNOUNCES SALE OF COMMON STOCK
Topics:


Related Articles
UNDERWRITERS' OPTION EXERCISED IN ARAMED UNIT OFFERING AND GENSIA COMMON STOCK OFFERING
AFFYMAX ANNOUNCES UNDERWRITERS HAVE EXERCISED OVER-ALLOTMENT OPTION OF 600,000 SHARES
IMMULOGIC FILES REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
IMMULOGIC ANNOUNCES PUBLIC OFFERING OF 2 MILLION SHARES OF COMMON STOCK AT $22.75 PER SHARE
NOVA PHARMACEUTICAL UNDERWRITERS EXERCISE OVER-ALLOTMENT OPTION
SONUS PHARMACEUTICALS ANNOUNCES EXERCISE OF UNDERWRITERS' OVER-ALLOTMENT OPTION
AMEX TO TRADE OPTIONS ON COOPER COMPANIES, INC. AND IMMULOGIC PHARMACEUTICAL CORPORATION
AMEX THIS MORNING OPENED OPTIONS TRADING ON COOPER COMPANIES AND IMMULOGIC PHARMACEUTICAL
ALEXION ANNOUNCES EXERCISE OF OVERALLOTMENT OPTION BY UNDERWRITERS
GELTEX PHARMACEUTICALS RAISES ADDITIONAL $8.5 MILLION THROUGH EXERCISE OF OVER-ALLOTMENT OPTION

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters